Search Results

You are looking at 1 - 7 of 7 items for :

  • "radiation dermatitis" x
Clear All
Full access

Barbara Burtness, Milan Anadkat, Surendra Basti, Miranda Hughes, Mario E. Lacouture, Joan S. McClure, Patricia L. Myskowski, Jennifer Paul, Clifford S. Perlis, Leonard Saltz and Sharon Spencer

severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes . Radiother Oncol 2009 ; 90 : 166 – 171 . 58 Mitra SS Simcock R . Erlotinib induced skin rash

Full access

Mario E. Lacouture

. Interestingly, the best treatment appears to be washing with soap and water, which is shown to almost halve the risk of radiation dermatitis. 8 The medium-strength topical corticosteroid mometasone was shown in randomized placebo-controlled trials to

Full access

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead and Rashmi Kumar

; 345 : 1378 – 1387 . 82. Pignol JP Olivotto I Rakovitch E . A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis . J Clin Oncol 2008 ; 26 : 2085 – 2092 . 83. Mukesh

Full access

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead and Rashmi Kumar

Olivotto I Rakovitch E . A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis . J Clin Oncol 2008 ; 26 : 2085 – 2092 . 32. Mukesh MB Barnett GC Wilkinson JS . Randomized

Full access

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead and Rashmi Kumar

radiotherapy with or without additional radiation . N Engl J Med 2001 ; 345 : 1378 – 1387 . 109. Pignol JP Olivotto I Rakovitch E . A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation

Full access

Al B. Benson III, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi-Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey Meyerhardt, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski and Deborah A. Freedman-Cass

-course arm were more likely to experience serious adverse events (eg, radiation dermatitis rates, 0% vs 5.6%; P =.003), whereas those in the short-course arm were more likely to have a permanent stoma (38.0% vs 29.8%; P =.13). 181 However, no overall

Full access

). Mean total dose was 45 Gy in 15 fractions for BCSC and 51 Gy in 17 fractions for SCSC. Grade 2 acute radiation dermatitis was higher in the kV group (76.9% vs 40.4%; P <.05), as were grade 1–2 late skin effects (21.4% vs 13.5%; P <.005). A